Article Sidebar
Published:
Jul 12, 2023DOI:
10.4314/tjpr.v22i6.1Keywords:
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
Development of a hydrogel containing metronidazoleloaded Eudragit RS 100 nanoparticles for buccal drug delivery
Abstract
Purpose: To formulate Eudragit RS 100-based nanoparticles containing metronidazole (MTZ NPs) and incorporate them into hydrogels using different gelling agents for controlled release in the buccal mucosa.
Method: MTZ NPs were fabricated using the nanoprecipitation method. MTZ NPs (1 % w/w) were introduced into hydrogels using different gelling excipients. Physicochemical properties of MTZ NPs, mucoadhesive strength and spreadability of the hydrogels, and ex vivo permeation of MTZ were evaluated.
Results: MTZ NPs were spherical in shape and had a mean particle size of 201.9 ± 5.6 nm, polydispersity index (PDI) of 0.092 ± 0.014, and encapsulation efficiency of 46.28 ± 1.18 %. Hydroxyethyl cellulose (HEC) hydrogel containing MTZ NPs showed homogenous and smooth appearance, mucoadhesive strength of 2789.7 ± 13.4 dyne/cm2 , and spreadability of 5.32 ± 0.77 cm. The cumulative amount of drug permeated from MTZ hydrogel and MTZ-containing NP hydrogel through porcine buccal mucosa was 1104.33 ± 28.97 and 397.62 ± 16.13 µg/cm2 , respectively, after 7 h (p < 0.05).
Conclusion: HEC hydrogel containing MTZ NPs demonstrates high mucoadhesive strength, good spreadability, and sustained ex vivo permeation of MTZ. Thus, HEC hydrogel is a promising pharmaceutical formulation for controlled drug release in the buccal mucosa
